C4 Therapeutics sets cemsidomide trial timelines through 2028
Go back to C4 Therapeutics sets cemsidomide trial timelines through 2028| Cache Capital Corp. (NASDAQ: CCCC) | Delayed: 3.87 +0.29 (8.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.58 | 52 Week High | $0.30 | |||
| Open | $3.57 | 52 Week Low | $0.30 | |||
| Day High | $3.89 | P/E | N/A | |||
| Day Low | $3.53 | EPS | $0.00 | |||
| Volume | 2,277,297 | |||||
